Literature DB >> 23193993

Associations between the functional polymorphisms in the ABCB1 transporter gene and colorectal cancer risk: a case-control study in Turkish population.

Gül Özhan1, Mehtap Kara, Fatih M Sari, Hakan T Yanar, Gulcin Ercan, Buket Alpertunga.   

Abstract

Colorectal cancer is among the most common cancer types in the world and its etiology involves the interaction of genetic and environmental factors. ABCB1 is highly expressed in the apical surface of colonic epithelial cells and acts as an efflux pump by transporting toxic endogenous substances, drugs and xenobiotics out of cells. ABCB1 polymorphisms may either change its protein expression or alter its function. Several studies have reported a possible association between ABCB1 variants and colorectal cancer, but no consistent conclusion has been arrived at. Therefore, we aimed to investigate the relationship between colorectal cancer and the functional common variants of ABCB1 (1236C > T; 2677G > T/A; 3435C > T). The distributions of the variants were determined in 103 patients with colorectal cancer and 150 healthy volunteers using polymerase chain reaction-restriction fragment length polymorphism methods. ABCB1 1236C > T was statistically significantly associated with colorectal cancer risk (OR, odd ratio = 1.91; 95% CI, confidence interval = 1.09-3.35; p = 0.034). In haplotype-based analysis, the proportion of individuals with the ABCB1 haplotype C1236-G2677-T3435 was significantly more common in patients than in controls (OR = 11.96; 95% CI = 2.59-55.32; p = 0.0004). We believe that the findings may be beneficial to the development of efficacious preventive strategies and therapies for colorectal cancer.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23193993     DOI: 10.3109/15376516.2012.743639

Source DB:  PubMed          Journal:  Toxicol Mech Methods        ISSN: 1537-6516            Impact factor:   2.987


  5 in total

1.  Association between the C3435T polymorphism of ABCB1/MDR1 gene (rs1045642) and colorectal cancer susceptibility : a meta-analysis based on 11,339 subjects.

Authors:  Li Zhao; Kai Li; Wusheng Li; Zhen Yang
Journal:  Tumour Biol       Date:  2013-03-16

Review 2.  Impact of Genetic Polymorphisms on Phenytoin Pharmacokinetics and Clinical Outcomes in the Middle East and North Africa Region.

Authors:  Renée Dagenais; Kyle John Wilby; Hazem Elewa; Mary H H Ensom
Journal:  Drugs R D       Date:  2017-09

3.  ABCB1 variants C3435T and T129C are not associated with colorectal cancer risk.

Authors:  Areej M Al Qahtani; Ayat B Al-Ghafari; Huda A Al Doghaither; Anas H Alzahrani; Ulfat M Omar; Sawsan A Rahimulddin
Journal:  Afr Health Sci       Date:  2019-09       Impact factor: 0.927

4.  Association between MDR1 polymorphisms and XELIRI and XELOX chemoresistance in Saudi patients with colorectal cancer.

Authors:  Ayat B Al-Ghafari; Areej M Al Qahtani; Suzan N Alturki; Huda A Al Doghaither; Ekramy M Elmorsy; Hanaa M Tashkandi; Atlal M Abusanad; Shadi S Alkhayyat; Ulfat M Omar; Ahmed A Zeeneldin
Journal:  Oncol Lett       Date:  2020-08-24       Impact factor: 2.967

5.  Association between ABCB1 (3435C>T) polymorphism and susceptibility of colorectal cancer: A meta-analysis.

Authors:  Li-Li Han; Bai-le Zuo; Wei-Liang Cai; Zhen-Ni Guo; Bing-Hua Tong; Hui-Lian Wei; Zheng Zhu; Guo-Yin Li
Journal:  Medicine (Baltimore)       Date:  2020-02       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.